arrow
F

Fakhar ud Din

quaid-i-azam university
H指数:43
被引数:6,420

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Targeted surface engineered magnetic nanoformulation for hepatocellular carcinoma: A preclinical approach to improve in vivo safety and bioavailability

靶向表面工程化磁性纳米制剂用于肝细胞癌:一种改善体内安全性和生物利用度的临床前方法

2026-04-150
PRE
Retraction notice to "Co-delivery of paclitaxel and curcumin loaded solid lipid nanoparticles for improved targeting of lung cancer: In vitro and in vivo investigation" [Heliyon 10 (2024) e30290]

撤稿通知:"Co-delivery of paclitaxel and curcumin loaded solid lipid nanoparticles for improved targeting of lung cancer: In vitro and in vivo investigation" [Heliyon 10 (2024) e30290]

Heliyon
IF3.6
2025-12-090
OAAI
Curzerenone attenuates neuroinflammation and oxidative stress via MAPK signaling pathway modulation: Network pharmacology and in vivo insights in a scopolamine-induced model of Alzheimer's disease

Curzerenone通过调节MAPK信号通路减轻神经炎症和氧化应激:网络药理学及在东莨菪碱诱导的阿尔茨海默病模型中的体内研究洞察

2025-12-010
OAAI
7β-(3-ethyl-cis-crotonoyloxy)-1α-(2-methylbutyryloxy)-3,14-dehydro-Z-notonipetranone (ECN) attenuates inflammation and oxidative stress via MAPK, and Nrf2/HO-1 signaling in Traumatic brain injury

7β-(3-乙基-顺式-巴豆酰氧基)-1α-(2-甲基丁酰氧基)-3,14-脱氢-Z-诺酮尼佩特兰酮(ECN)通过MAPK、Nrf2/HO-1信号通路减轻创伤性脑损伤中的炎症和氧化应激。

2025-07-010
PRE
Unveiling the potential of nano-structured lipid carriers for oral administration of cefepime: Bioavailability and safety investigations

揭示纳米结构脂质载体用于头孢吡肟口服给药的潜力:生物利用度与安全性研究

2025-05-090
PRE